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Conclusions: The knee cartilage of the Hartley guinea pig undergoes
an increase in the expression of genes associated with hypertrophy by
12 months of age coincident with the development of severe osteoarthritic
changes. Compared to the OA-prone Hartley strain, Strain 13 guinea pig
knee cartilage showed much lower expression of genes associated with
the hypertrophic cartilage phenotype. These ﬁndings are compatible with
the lesser severity of OA in this model. Interestingly, Hartley and Strain 13
guinea pigs showed similar and high ADAMTS-5 mRNA expression,
suggesting that ADAMTS-5 may be relevant in OA development in the
guinea pig model, but may not account for the differential susceptibility of
the two strains to OA.
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Purpose: The Frizzled related protein (FRZB) gene has been associ-
ated with susceptibility to osteoarthritis in different cohorts. FRZB is a
secreted antagonist of the WNT signaling pathway originally identiﬁed in
a chondrogenic extract of articular cartilage. We have generated Frzb−/−
mice and demonstrated that this loss of function model shows increased
cartilage damage in different induced mouse models of osteoarthritis.
Deletion of Frzb is associated with increased Wnt signaling and increased
matrix metalloproteinase activity and expression. In addition, cortical bone
thickness and adaptive bone formation upon loading are increased in
Frzb−/− mice as compared to wild-types. Here, we further evaluated the
spontaneous development of knee and hip osteoarthritis in a cohort of
normal aging mice as well as a cohort of mice exposed to voluntary
running activity. In addition we studied the effect of Frzb deletion on
enthesophyte/osteophyte formation in the spontaneous model of arthritis
in DBA/1 mice.
Methods: Aging Frzb−/− and wild-type mice were evaluated by X-rays
at week 26 and 52. In another cohort, Frzb−/− and wild-type mice were
grouped and a running wheel was introduced into the cage at the age of
7 weeks. At week 8, all mice were caged solitarily with a running wheel
available. Mice were allowed free exercise for 6 to 12 months and dis-
tances run were recorded daily. At the end of the experiment, mice were
sacriﬁced and joints were processed for histological evaluation. Cartilage
damage, synovitis and osteophyte formation were scored. Muscle ﬁber
composition of the soleus and extensor digitorum longus were studied
by immunoﬂuorescence. Frzb−/− mice were backcrossed onto the DBA/1
background for over 7 generations. Male DBA/1 mice from different litters
were caged together at the age of 10 weeks (>5 males per cages) and
observed for clinical signs of arthritis. Alternatively wildtype DBA/1 males
were treated with intramuscular injections of plasmid containing Frzb
under control of a CMV promoter every three weeks (week 11, 14, 17
and 20). At the end of these experiments (week 30 and 25 respectively),
mice were sacriﬁced and histological severity of disease was evaluated.
Results: No statistical differences in spontaneous incidence or severity
of osteoarthritis were seen between Frzb−/− mice and wild-type mice.
At the age of 6 months, both female and male wild-type mice showed
signiﬁcantly greater voluntary running activity than the Frzb−/− mice
(p< 0.05). At one year, the difference was still signiﬁcant for male mice,
but not for females. Running exercise did not signiﬁcantly affect severity
of osteoarthritis. Differences in distances run were not explained by
abnormalities in muscle composition.
In the spontaneous model of joint remodeling, average clinical disease
severity score and average clinical severity score per affect animal were
higher in wildtype as compared to Frzb−/− mice. Average histomor-
phological severity score was also higher in wild-type as compared to
Frzb−/− mice. In contrast, overexpression of Frzb by intramuscular plasmid
injection did not affect clinical incidence, severity and histomorphological
disease severity scores.
Conclusions: Absence of Frzb in mice does not lead to increased inci-
dence or severity of osteoarthritis. However, reduced voluntary physical
activity in running wheels suggests that absence of Frzb affects locomo-
toric function. The underlying mechanisms are not yet fully understood.
Deletion of Frzb also reduces endochondral bone formation in a mouse
model of ankylosis. These combined data further establish a role of FRZB
and WNT signaling in postnatal musculoskeletal biology and disease.
Functional polymorphisms in FRZB in humans may also affect osteophyte
formation and disease progression
66 ORAL CALCITONIN REDUCES CARTILAGE EROSION IN AN
OA RAT MODEL WITH BOTH TRAUMATIC INJURY AND
INCREASED SUBCHONDRAL BONE TURNOVER
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Purpose: Osteoarthritis (OA) is a disease that affects the entire artic-
ular joint, with both changes to the bone and cartilage compartments.
Increased bone turnover, as caused by oestrogen deﬁciency, has been
speculated to augment the severity of cartilage erosion and to accelerate
the pathogenesis of OA. An optimal intervention strategy for OA may
therefore ideally target both bone and cartilage mal metabolisms. Calci-
tonin has been shown to affect both osteoclasts and chondrocytes. We
investigated whether a novel oral formulation of salmon calcitonin could
reduce cartilage erosion and attenuate osteophyte formation, observed
secondary to induction of OA by combined partial medial meniscectomy
and ovariectomy of rats.
Methods: Four groups of 6 months old rats were subjected to sham,
ovariectomy (OVX) or a combined ovariectomy and partial medial menis-
cectomy (OVX+MNX) and administered twice daily with oral salmon
calcitonin (CT) (150mg/kg 5-CNAC + 2mg/kg calcitonin) or vehicle control
(V) (150mg/kg 5-CNAC) in the following way: (1) Sham+V; (2) OVX+V;
(3) OVX+MNX+V; (4) OVX+MNX+CT. Serum samples were collected at
baseline and 3, 6 and 8 weeks after surgery, and weights were recorded
at regular intervals. Animals were sacriﬁced 8 weeks after surgery, and
the tibia was processed for histology. C-terminal telopeptide of type II
collagen (CTX-II) was measured in the serum. Histological sections were
stained with Fast Green/Safranin O. The tibial plateau was equally divided
into a medial, central and lateral compartment, subsequently analysed
separately where the area of articular cartilage was measured using
automatic delineations in ImagePro. Areas of osteophytes situated in the
lateral compartment were scored separately.
Results:OVX surgery increased serum CTX-II levels by 260%, 240% and
53% in week 3, 6 and 8 after surgery, respectively. Meniscectomy did not
further increase the systemic CTX-II levels. Treatment with oral calcitonin
signiﬁcantly (p< 0.05) reduced CTX-II concentrations to below sham
levels. Ovariectomy alone resulted in a moderate cartilage loss of 5.8%
in the central tibial compartment compared to sham animals, whereas
OVX+MNX+V caused a heavy 33.3% (p< 0.05) cartilage loss. Treatment
with oral calcitonin reduced that cartilage loss by 52% (p=0.06). The
area of laterally occurring osteophytes increased 15-fold (p< 0.01) from
OVX+V to OVX+MNX+V animals. The effects of oral calcitonin reduced
the area of osteophytes by 55% when comparing the group OVX+MNX+V
to OVX+MNX+CT.
Conclusions: Currently there are no treatments available for OA. These
data are the ﬁrst to demonstrate that an oral formulation of calcitonin
protects against cartilage erosion and osteophyte formation in an in vivo
OA model with both traumatic injury and increased subchondral bone
turnover. The chondroprotective effects of salmon calcitonin may be a
combination of direct effect on chondrocytes in addition to the well-
established effect on bone resorption. Further clinical studies are needed
to validate the herein documented effects on cartilage erosion.
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Purpose: Since the prevalence of osteoarthritis OA is much higher in
postmenopausal than in premenopausal women, and cartilage damage
is increased after ovariectomy in several animal models, it is believed
that estrogen depletion plays a role in the onset or progression of OA.
Estrogen acts via the estrogen receptors (ERs) a and b. It is known
that deletion of ERs leads to changes in the metaphyseal bone. We
hypothesize that deletion of one or both estrogen receptors in female
mice will promote osteoarthritic changes in the cartilage and subchondral
bone.
Our aim was to study cartilage and subchondral bone changes
in knee joints of female ERalpha−/−, ERbeta−/−, and double
ERalpha−/−ERbeta−/− mice.
Methods: Tibias of 6-month-old female ERalpha−/−, ERbeta−/−, and
ERalpha−/−ERbeta−/− mice and their wildtype (wt, C57Bl/6 background)
littermates (n6 per group) were analyzed with microCT and histology.
